10th Symposium Advanced Ovarian Cancer, Valencia
El viernes 6 de marzo se convoca el 10th International Symposium. Advanced Ovarian Cancer: Optimal Therapy, organizado por el Dr Andrés Poveda de la Fundación Instituto Valenciano de Oncología y el Dr. Jan B. Vermorken del Antwerp University Hospital, Edegem, Belgium. Se celebra en el Palau de la Música «Iturbi» Meeting room. Pº de la Alameda, 30. 46023 Valencia.
ASACO acude representada por Paloma y Theresa, coordinadoras de los grupos de apoyo de Valencia y Barcelona respectivamente. Más info.
-
- Cartel del Simposio de 2015
-
- Theresa, Dra. Bratos y Paloma.
A través de los enlaces de la siguiente tabla se puede acceder a las presentaciones de acceso público realizadas en el 10th International Symposium. Advanced Ovarian Cancer: Optimal Therapy,
| PRESENTER | PRESENTATION TITLE | SESSION TITLE |
|---|---|---|
| Stanley B. Kaye | Progress in the treatment of ovarian cancer. Lessons from Homologous Recombination Deficiency | Keynote Lecture |
| Michael J. Birrer | The molecular genetics of epithelial ovarian cancer | Critical issues for further development in ovarian cancer |
| Andreas du Bois | Borderline Tumors of the Ovary: the ROBOT study (AGO-OVAR OP.5) and more | Innovations in the approach to borderline tumours and epithelial ovarian cancer |
| Bradley J. Monk | Antiangiogenic agents | Clinical impact of targeted therapies |
| Jonathan Ledermann | PARP inhibition in ovarian cancer | Clinical impact of targeted therapies |
| David R. Spriggs | Other targeted agents. New therapeutic approaches to serous ovarian cancer | Clinical impact of targeted therapies |
| David M. Gershenson | Low-grade serous carcinoma of the ovary or peritoneum | Differentiated approach to epithelial ovarian cancer |
| Timothy Perren | Mucinous ovarian carcinoma | Differentiated approach to epithelial ovarian cancer |
| Michael Bookman | Primary disease – Primary therapy | Standard of care of ovarian cancer in 2015 |
| Eric Pujade-Lauraine | Recurrent disease | Standard of care of ovarian cancer in 2015 |
| Michael Friedlander | Patient reported outcomes in ovarian cancer clinical trials. Missed opportunities | Standard of care of ovarian cancer in 2015 |
Noticias relacionadas:
– El Periodic.com (7/3/2015): «Especialistas mexicanos de Oncología visitan el Clínico y el Instituto INCLIVA«.
